From October 28, 2023 to January 26, 2024, the company has repurchased 1,598,724 shares, representing 0.12% for $124.16 million. With this, the company has completed the repurchase of 92,465,168 shares, representing 6.87% for $9,082.87 million under the buyback announced on June 23, 2017.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
81.38 USD | -0.38% | +1.04% | -0.83% |
Apr. 26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
Apr. 26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.83% | 108B | |
-3.91% | 184B | |
-2.55% | 67.82B | |
+4.56% | 51.05B | |
+9.15% | 44.67B | |
+3.40% | 41.78B | |
+2.08% | 26.78B | |
+4.12% | 26.59B | |
+15.23% | 25.86B | |
-1.13% | 25.03B |
- Stock Market
- Equities
- MDT Stock
- News Medtronic plc
- Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.